DOL Increases Civil Penalty Amounts for 2020
02/13/2020
On Jan. 15, 2020, the Department of Labor (DOL) released its 2020 inflation-adjusted civil monetary penalties that may be assessed on employers for violations of a wide range of federal laws, including those listed here.
Read MoreThe State of the Union Address and the Employee Benefits Market
02/05/2020
On Tuesday, Feb. 4, 2020, President Donald Trump delivered the 2020 State of the Union Address (SOTU). This News Brief provides an overview of the employee benefits-related topics that were covered in the 2020 SOTU.
Read MoreThings to Know About Coronavirus
02/03/2020
This Live Well, Work Well article provides an overview of coronavirus including symptoms, diagnosis, and prevention.
Read More5 Employee Benefits Developments to Watch in 2020
01/24/2020
Linked below is important information regarding Employee Benefits in 2020.
Read MoreImportant Tax Information for Guardian Short Term and Long Term Disability Insurance Programs
01/15/2020
Linked below is important information from Guardian regarding the short term and/or long term disability insurance program.
Read MoreDOL Announces Increased Civil Penalties for 2020
01/15/2020
On Jan. 15, 2020, the Department of Labor (DOL) released its 2020 inflation-adjusted civil monetary penalties that may be assessed on employers for violations of a wide range of federal laws.
Read MoreAmazon rolls out new Alexa feature to let consumers refill prescriptions
11/26/2019
FierceHealthcare
Read MorePennsylvania takes another step toward launching state-based insurance exchange
11/26/2019
FierceHealthcare
Read MoreThe most remote emergency room: Life and death in rural America
11/16/2019
The Washington Post
Read MoreLeapfrog released its new safety grades. It's also facing a lawsuit challenging its methods
11/08/2019
Fierce Healthcare
Read MoreObscure Model Puts a Price on Good Health—and Drives Down Drug Costs
11/04/2019
The makers of the cholesterol-lowering drug Praluent, which first went on sale for $14,600, offered to sell it for as little as $4,500, after rebates. A new migraine drug called Aimovig, expected to cost up to $10,000 a year, went on sale for $6,900. And Zolgensma, a lifesaving gene therapy for children that its maker said might cost up to $5 million, was priced at $2.1 million.
Read MoreUHC policy will limit outpatient surgery payments to hospitals
10/29/2019
Becker's Hospital Review
Read MoreExclusive Benefit—An Analysis of Pharmacy Benefit Managers as Potential ERISA Fiduciaries
10/04/2019
Bloomberg Law
Read MoreSam's Club launches healthcare pilot program for members
09/26/2019
Becker's Hospital Review
Read MoreWalmart unveils plan to build healthcare workforce: 5 things to know
09/24/2019
Becker's Hospital Review
Read MoreEmployers, Employees Lack Knowledge Of HSAs, Report Says
09/23/2019
Financial Advisor Magazine
Read MorePCI Welcomes Jason Benjamin
08/16/2019
Pennsylvania Chamber Insurance is pleased to welcome Jason Benjamin, Benefits Consultant in the Lehigh Valley where he is responsible for service and retention of PCI’s existing insurance customers, and to affirm a customer-centric presence in the eastern region of the state. He works in tandem with the PCI sales team to ease the transition for oncoming prospects to satisfied customers. As a previous long-standing member of the PCI team, Jason returns after working with Kistler Tiffany Benefits.
A CONVERSATION WITH BRIAN ORSINGER
07/15/2019
Brian Orsinger, 39, is COO of Pennsylvania Chamber Insurance in Harrisburg. Prior to joining PA Chamber Insurance this year, he held positions at Key Insurance & Benefits Services, First Niagara Benefits Consulting, Banyan Consulting and Sovereign Benefits Consulting. He started his career in finance at Select Medical Corp.